Regulation - Healthcare, Pricing

Filter

Current filters:

HealthcarePricing

Popular Filters

Undervaluing new medicines threatens patient wellbeing and economic growth; report

Undervaluing new medicines threatens patient wellbeing and economic growth; report

14-03-2014

Innovative medicines and other new therapies have extended life expectancy by some 10 years since the…

HealthcareNorthern EuropePharmaceuticalPricingRegulationUK

Ahead of 2013 federal election, trade group makes plea for fixing Australia's PBS listing system

27-05-2013

Pharma trade group Medicines Australia today (May 27) launched its 2013 Federal Election document, calling…

Asia-PacificHealthcarePatentsPharmaceuticalPoliticsPricingRegulation

BRICs not delivering promises of high growth in health care markets, says F&S

24-05-2013

Health care organizations expanding into emerging markets such as the BRICs (Brazil, Russia, India and…

HealthcareMarkets & MarketingPharmaceuticalPricingRegulation

Progress on better access to medicines for patients in Europe

19-04-2013

Significant progress was made in the work of the Process on Corporate Responsibility in the field of…

BiotechnologyEuropeHealthcarePharmaceuticalPricingRegulation

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

03-12-2012

Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

"India Pharma Inc" gearing up for the next level of growth

05-11-2012

Indian pharmaceutical companies will have to rethink business strategy in the light of several interventions…

Asia-PacificGenericsHealthcareMarkets & MarketingPharmaceuticalPricingProductionRegulation

Scotland denies access to Roche skin cancer drug Zelboraf, but OKs Novartis' Gilenya

11-09-2012

Swiss drug major Roche (ROG SIX) says it is "extremely disappointed" that the Scottish Medicines Consortium…

EuropeGilenyaHealthcareNeurologicalNovartisOncologyPharmaceuticalPricingRegulationRocheZelboraf

Europe's drug pricing sent askew by economic crash

22-08-2012

The European Union faced further fallout from the global financial crisis this year, and the region's…

EuropeHealthcarePharmaceuticalPricingRegulation

US patients get faster access to more cancer drugs than Europeans, says Tufts

11-07-2012

Cancer patients in the USA get faster access to more oncology drugs to treat their disease than patients…

BiotechnologyEuropeHealthcareNorth AmericaOncologyPharmaceuticalPricingRegulation

Australia's health care regulations struggle to keep up with population aging

10-07-2012

The growing elderly population and its associated disease burden add to the economic challenges faced…

Asia-PacificHealthcareMarkets & MarketingPharmaceuticalPricingRegulation

Australian patients to benefit from new PBS listings; OTC reforms

26-06-2012

The listing of 11 prescription medicines on the Australian Pharmaceutical Benefits Scheme (PBS) has been…

Asia-PacificBiotechnologyHealthcarePharmaceuticalPricingRegulation

European generics trade group urges addressing medicines affordability and availability risks

17-06-2012

With pensioners set to represent over 60% of the working population by 2060 in Europe, the pharmaceutical…

EuropeGenericsHealthcarePricingRegulation

Ukraine to introduce reference pricing and plans for prescription system

01-05-2012

The Ukraine Ministry of Health and domestic producers of pharmaceuticals have signed a memorandum of…

EuropeGenericsHealthcarePharmaceuticalPricingRegulation

Portuguese hospitals block access to new medicines as retail drug sector expected to meet savings goal

30-09-2011

Access to expensive medicines is becoming increasingly difficult in Portuguese public hospitals, while…

EuropeHealthcarePfizerPharmaceuticalPricingRare diseasesRegulationVyndaqel

Company Spotlight

ImmunoGen

ImmunoGen

Back to top